A detailed history of Ever Source Wealth Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 45 shares of CORT stock, worth $2,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 45 -0.0%
Holding current value
$2,465
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$22.21 - $34.48 $155 - $241
7 Added 18.42%
45 $1,000
Q1 2024

Jun 11, 2024

BUY
$21.1 - $27.46 $126 - $164
6 Added 18.75%
38 $0
Q3 2023

Nov 03, 2023

BUY
$21.97 - $33.8 $703 - $1,081
32 New
32 $0
Q3 2022

Nov 07, 2022

BUY
$24.7 - $29.12 $1,457 - $1,718
59 New
59 $2,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.87B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.